Dexamethasone Therapy in Patients With Brain Tumors - A Focus on Tapering

Ann E. Nahaczewski; Susan B. Fowler; S. Hariharan


J Neurosci Nurs. 2004;36(6):340-343. 

In This Article

Drug Interactions

Phenytoin, an antiepileptic medication frequently prescribed for seizure prophylaxis in patients following neurosurgery, has been shown to decrease the serum half-life of dexamethasone by increasing its metabolism. This interaction may account for the variations in the optimal dexamethasone dose in a large number of brain tumor patients receiving prophylactic anti-epileptic medications. Phenobarbital, another antiepileptic medication, has also demonstrated a similar effect on dexamethasone. Both of these agents are potent inducers of the hepatic microsomal enzyme system, which would explain their effect on dexamethasone metabolism. Hence, newer anti-epileptic drugs with no hepatic enzyme inhibition, such as gabapentin and levetiracetam, may be preferable for patients who need seizure prophylaxis. The interaction of dexamethasone and other anti-epileptic drugs has not been well studied. Careful monitoring and dose adjustments may be required to achieve therapeutic drug concentrations (Gattis & May, 1996).


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: